BSE filing, NSE: APOLLOFI. Summary written from the filing by ALFA Finder's alert engine.
Apollo Finvest (India) Ltd: key numbers
- Share price
- ₹448.00
- Market cap
- ₹167.2 Cr
- Revenue (annual)
- ₹20.70 Cr
- Net profit (annual)
- ₹6.95 Cr
- P/E (TTM)
- 20.9×Sector 33.5×
- Promoter holding
- 70.70%+0.00% QoQ
- FII holding
- 0.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apollo Finvest (India) Ltd
All →Apollo Finvest (India) Debt & Borrowing: ₹15 Cr
Apollo Finvest (India) Ltd. announced a revision in the interest rate on its existing ₹15 Crore non-convertible debentures from 9.75% to 10%, effective October 7, 2026.
- Value
- ₹15.00 Cr
Apollo Finvest (India) Adverse Business Impact
Apollo Finvest reported a cyber fraud incident involving a joint partnership account. The company's share of the fraudulent transfer is approximately ₹2.94 Crore.
- Value
- ₹2.94 Cr
Apollo Finvest (India) Management Change
Apollo Finvest reappointed Mikhil Innani as Managing Director and appointed Pranay D. Vaidya & Co. as Secretarial Auditor.
Apollo Finvest (India) Annual General Meeting
Apollo Finvest (India) Ltd. held its 40th Annual General Meeting on September 17, 2026. The meeting successfully transacted all listed ordinary and special business items.
Apollo Finvest (India) Price Movement Clarification
Apollo Finvest clarified that the recent movement in its scrip price is purely market-driven and not due to any undisclosed company information.
Apollo Finvest (India) Employee Stock Options
Apollo Finvest (India) Ltd allotted 390 equity shares to employees upon exercise of stock options under the AFIL-2022 plan.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.